跳至主要内容
临床试验/IRCT20220516054874N17
IRCT20220516054874N17招募中3 期

Investigating the effect of rose hip alcoholic extract on the ventricular arrhythmia in heart failure patients with Implantable Cardioverter Defibrillator

Mashhad University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age older than 18 years old
  • Heart failure diagnosis
  • ICD implantation > 6 months before eligibility test
  • Signed written informed consent to participate in the study

排除标准

  • New York Heart Association Class IV heart failure
  • Renal dysfunction with eGFR < 20
  • Hepatic dysfunction
  • Body mass index < 18.5 kg/m2
  • Pregnant or suspected pregnancy
  • Patients with the following events within 3months before the eligibility test: alteration of antiarrhythmic drug, catheter ablation for ventricular arrhythmia, coronary revascularization, open-heart surgery, development of coronary artery disease, stroke or transient ischemic stroke, seizure, infection requiring hospitalization, heart failure requiring hospitalization
  • Other comorbidities including various infections, major surgery, type 1 diabetes, pituitary or adrenal insufficiency, cancer
  • ICDs unable to record cardiac arrhythmias

研究者

相似试验